Pharmaceutical composition comprising a combination of an activated form of the enhanced Antibody s-100 Protein and an activated form potentiated Antibody anti TNF - Alpha； methods for Treatment of diseases or Functional conditions of the Gastrointestinal Tract.
The present invention provides a combination pharmaceutical composition comprising a) an activated-potentiated form of an antibody to a S-100 protein, b) an activated-potentiated form of an antibody to histamine, and c) an activated-potentiated form of an antibody to TNF-alpha. Various embodiments and variants are provided. The present invention further provides a method of treating a disease or condition of functional etiology of the gastrointestinal tract, said method comprising administering to a patient in need thereof a combination pharmaceutical composition comprising a) an activated-potentiated form of an antibody to a histamine, b) an activated-potentiated form of an antibody to S-100 protein and c) an activated-potentiated form of an antibody to TNF-alpha. Various embodiments and variants are provided.La presente solicitud describe una combinación farmacéutica que comprende a) una mezcla de disoluciones en un factor de 100^12, 100^30 y 100^200 de un anticuerpo de la proteína S-100, b) una mezcla de disoluciones en un factor de 100^12, 100^30 y 100^200 de un anticuerpo anti-histamina, y c) una mezcla de disoluciones en un factor de 100^12, 100^30 y 100^200 de un anticuerpo anti-TNFa, y su uso para fabricar un medicamento útil para el tratamiento de enfermedades o condiciones de etiología funcional del tracto gastrointestinal.
